middle.news
Botanix’s Sofdra momentum survives a sweeping cost reset
9:31am on Tuesday 27th of October, 2026 AEDT
•
Pharmaceuticals
Read Story
Botanix’s Sofdra momentum survives a sweeping cost reset
9:31am on Tuesday 27th of October, 2026 AEDT
Key Points
Sofdra prescriptions shipped rose 5.3% to 35,130
Net revenue held at $10.1 million despite higher gross sales
Cash fell to $24.4 million after $9.2 million of operating outflows
October cost actions target a roughly 50% reduction in annual operating expenses
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Botanix Pharmaceuticals (ASX:BOT)
OPEN ARTICLE